nodes	percent_of_prediction	percent_of_DWPC	metapath
Diclofenac—SLC22A11—Furosemide—dilated cardiomyopathy	0.18	0.304	CbGbCtD
Diclofenac—SLC22A8—Furosemide—dilated cardiomyopathy	0.105	0.177	CbGbCtD
Diclofenac—SLC22A6—Furosemide—dilated cardiomyopathy	0.0731	0.123	CbGbCtD
Diclofenac—CYP2C8—Spironolactone—dilated cardiomyopathy	0.0704	0.119	CbGbCtD
Diclofenac—ALB—Furosemide—dilated cardiomyopathy	0.0622	0.105	CbGbCtD
Diclofenac—ABCB1—Lisinopril—dilated cardiomyopathy	0.0541	0.0913	CbGbCtD
Diclofenac—ABCB1—Spironolactone—dilated cardiomyopathy	0.0477	0.0804	CbGbCtD
Diclofenac—CYP2C9—cardial valve—dilated cardiomyopathy	0.0105	0.222	CbGeAlD
Diclofenac—CXCR1—heart—dilated cardiomyopathy	0.00536	0.114	CbGeAlD
Diclofenac—ASIC1—heart—dilated cardiomyopathy	0.00319	0.0678	CbGeAlD
Diclofenac—PLA2G2A—cardiac ventricle—dilated cardiomyopathy	0.00292	0.0622	CbGeAlD
Diclofenac—PLA2G2A—myocardium—dilated cardiomyopathy	0.00275	0.0585	CbGeAlD
Diclofenac—KCNQ3—heart—dilated cardiomyopathy	0.00253	0.0539	CbGeAlD
Diclofenac—Clonidine—SLC22A5—dilated cardiomyopathy	0.00192	1	CrCbGaD
Diclofenac—PLA2G2A—heart—dilated cardiomyopathy	0.00192	0.0409	CbGeAlD
Diclofenac—CXCL8—heart—dilated cardiomyopathy	0.0019	0.0405	CbGeAlD
Diclofenac—PLA2G2A—cardiac atrium—dilated cardiomyopathy	0.00164	0.035	CbGeAlD
Diclofenac—SCN4A—heart—dilated cardiomyopathy	0.00149	0.0317	CbGeAlD
Diclofenac—TTR—heart—dilated cardiomyopathy	0.00145	0.0309	CbGeAlD
Diclofenac—ALOX5—heart—dilated cardiomyopathy	0.00131	0.028	CbGeAlD
Diclofenac—ABCC1—myocardium—dilated cardiomyopathy	0.00109	0.0233	CbGeAlD
Diclofenac—Cough increased—Lisinopril—dilated cardiomyopathy	0.000967	0.00501	CcSEcCtD
Diclofenac—Alopecia—Spironolactone—dilated cardiomyopathy	0.000963	0.00498	CcSEcCtD
Diclofenac—Oliguria—Lisinopril—dilated cardiomyopathy	0.000961	0.00498	CcSEcCtD
Diclofenac—Deafness—Furosemide—dilated cardiomyopathy	0.000958	0.00496	CcSEcCtD
Diclofenac—Vascular purpura—Furosemide—dilated cardiomyopathy	0.000958	0.00496	CcSEcCtD
Diclofenac—Haemolytic anaemia—Furosemide—dilated cardiomyopathy	0.000949	0.00491	CcSEcCtD
Diclofenac—Gout—Lisinopril—dilated cardiomyopathy	0.000949	0.00491	CcSEcCtD
Diclofenac—Creatinine increased—Lisinopril—dilated cardiomyopathy	0.00093	0.00482	CcSEcCtD
Diclofenac—ALB—heart—dilated cardiomyopathy	0.000925	0.0197	CbGeAlD
Diclofenac—CYP1A1—cardiac ventricle—dilated cardiomyopathy	0.000914	0.0195	CbGeAlD
Diclofenac—Muscle spasms—Spironolactone—dilated cardiomyopathy	0.000912	0.00472	CcSEcCtD
Diclofenac—Dermatitis exfoliative—Furosemide—dilated cardiomyopathy	0.000908	0.0047	CcSEcCtD
Diclofenac—Vasculitis—Lisinopril—dilated cardiomyopathy	0.000907	0.0047	CcSEcCtD
Diclofenac—Thirst—Furosemide—dilated cardiomyopathy	0.0009	0.00466	CcSEcCtD
Diclofenac—Dermatitis bullous—Furosemide—dilated cardiomyopathy	0.000897	0.00464	CcSEcCtD
Diclofenac—Neck pain—Lisinopril—dilated cardiomyopathy	0.000896	0.00464	CcSEcCtD
Diclofenac—ABCC4—heart—dilated cardiomyopathy	0.000895	0.0191	CbGeAlD
Diclofenac—Purpura—Furosemide—dilated cardiomyopathy	0.000889	0.0046	CcSEcCtD
Diclofenac—Anaphylactoid reaction—Furosemide—dilated cardiomyopathy	0.000885	0.00458	CcSEcCtD
Diclofenac—Ill-defined disorder—Spironolactone—dilated cardiomyopathy	0.00088	0.00456	CcSEcCtD
Diclofenac—Lethargy—Furosemide—dilated cardiomyopathy	0.000874	0.00453	CcSEcCtD
Diclofenac—Cystitis noninfective—Lisinopril—dilated cardiomyopathy	0.000865	0.00448	CcSEcCtD
Diclofenac—Wheezing—Lisinopril—dilated cardiomyopathy	0.00086	0.00445	CcSEcCtD
Diclofenac—Malaise—Spironolactone—dilated cardiomyopathy	0.000855	0.00443	CcSEcCtD
Diclofenac—Cystitis—Lisinopril—dilated cardiomyopathy	0.000855	0.00443	CcSEcCtD
Diclofenac—Leukopenia—Spironolactone—dilated cardiomyopathy	0.000849	0.0044	CcSEcCtD
Diclofenac—Fluid retention—Lisinopril—dilated cardiomyopathy	0.000841	0.00435	CcSEcCtD
Diclofenac—Irritability—Furosemide—dilated cardiomyopathy	0.000818	0.00423	CcSEcCtD
Diclofenac—Blood creatinine increased—Furosemide—dilated cardiomyopathy	0.000803	0.00416	CcSEcCtD
Diclofenac—Bladder pain—Lisinopril—dilated cardiomyopathy	0.000801	0.00415	CcSEcCtD
Diclofenac—Discomfort—Spironolactone—dilated cardiomyopathy	0.000798	0.00413	CcSEcCtD
Diclofenac—Lightheadedness—Lisinopril—dilated cardiomyopathy	0.000792	0.0041	CcSEcCtD
Diclofenac—Confusional state—Spironolactone—dilated cardiomyopathy	0.000781	0.00404	CcSEcCtD
Diclofenac—Hypertonia—Lisinopril—dilated cardiomyopathy	0.000776	0.00402	CcSEcCtD
Diclofenac—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.000774	0.00401	CcSEcCtD
Diclofenac—Cramp muscle—Furosemide—dilated cardiomyopathy	0.000772	0.00399	CcSEcCtD
Diclofenac—Toxic epidermal necrolysis—Furosemide—dilated cardiomyopathy	0.000772	0.00399	CcSEcCtD
Diclofenac—ABCC1—heart—dilated cardiomyopathy	0.000764	0.0163	CbGeAlD
Diclofenac—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.000758	0.00392	CcSEcCtD
Diclofenac—Muscular weakness—Furosemide—dilated cardiomyopathy	0.000756	0.00391	CcSEcCtD
Diclofenac—PTGS1—myocardium—dilated cardiomyopathy	0.000755	0.0161	CbGeAlD
Diclofenac—Abdominal distension—Furosemide—dilated cardiomyopathy	0.000746	0.00386	CcSEcCtD
Diclofenac—Sleep disorder—Lisinopril—dilated cardiomyopathy	0.000743	0.00385	CcSEcCtD
Diclofenac—Hepatic function abnormal—Lisinopril—dilated cardiomyopathy	0.000736	0.00381	CcSEcCtD
Diclofenac—Eosinophilia—Furosemide—dilated cardiomyopathy	0.000733	0.0038	CcSEcCtD
Diclofenac—Photosensitivity—Lisinopril—dilated cardiomyopathy	0.000732	0.00379	CcSEcCtD
Diclofenac—Pancreatitis—Furosemide—dilated cardiomyopathy	0.000726	0.00376	CcSEcCtD
Diclofenac—Gastroenteritis—Lisinopril—dilated cardiomyopathy	0.000725	0.00376	CcSEcCtD
Diclofenac—Hepatic failure—Lisinopril—dilated cardiomyopathy	0.000715	0.0037	CcSEcCtD
Diclofenac—Eczema—Lisinopril—dilated cardiomyopathy	0.000715	0.0037	CcSEcCtD
Diclofenac—Haemolytic anaemia—Lisinopril—dilated cardiomyopathy	0.000712	0.00369	CcSEcCtD
Diclofenac—Injury—Lisinopril—dilated cardiomyopathy	0.000699	0.00362	CcSEcCtD
Diclofenac—Renal failure acute—Lisinopril—dilated cardiomyopathy	0.000696	0.00361	CcSEcCtD
Diclofenac—Somnolence—Spironolactone—dilated cardiomyopathy	0.000688	0.00356	CcSEcCtD
Diclofenac—Pollakiuria—Furosemide—dilated cardiomyopathy	0.000684	0.00354	CcSEcCtD
Diclofenac—Photosensitivity reaction—Furosemide—dilated cardiomyopathy	0.000676	0.0035	CcSEcCtD
Diclofenac—Renal impairment—Lisinopril—dilated cardiomyopathy	0.000676	0.0035	CcSEcCtD
Diclofenac—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.000668	0.00346	CcSEcCtD
Diclofenac—Hyperglycaemia—Furosemide—dilated cardiomyopathy	0.000668	0.00346	CcSEcCtD
Diclofenac—Anaphylactoid reaction—Lisinopril—dilated cardiomyopathy	0.000664	0.00344	CcSEcCtD
Diclofenac—Arthritis—Lisinopril—dilated cardiomyopathy	0.000662	0.00342	CcSEcCtD
Diclofenac—Drowsiness—Furosemide—dilated cardiomyopathy	0.00066	0.00342	CcSEcCtD
Diclofenac—Hypoglycaemia—Lisinopril—dilated cardiomyopathy	0.000659	0.00341	CcSEcCtD
Diclofenac—Cerebrovascular accident—Lisinopril—dilated cardiomyopathy	0.000656	0.0034	CcSEcCtD
Diclofenac—Stevens-Johnson syndrome—Furosemide—dilated cardiomyopathy	0.000655	0.00339	CcSEcCtD
Diclofenac—ABCC1—cardiac atrium—dilated cardiomyopathy	0.000653	0.0139	CbGeAlD
Diclofenac—Renal failure—Furosemide—dilated cardiomyopathy	0.000649	0.00336	CcSEcCtD
Diclofenac—Diplopia—Lisinopril—dilated cardiomyopathy	0.000643	0.00333	CcSEcCtD
Diclofenac—Pain in extremity—Lisinopril—dilated cardiomyopathy	0.000643	0.00333	CcSEcCtD
Diclofenac—Osteoarthritis—Lisinopril—dilated cardiomyopathy	0.000643	0.00333	CcSEcCtD
Diclofenac—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.000638	0.0033	CcSEcCtD
Diclofenac—Sweating—Furosemide—dilated cardiomyopathy	0.000633	0.00328	CcSEcCtD
Diclofenac—Hepatobiliary disease—Furosemide—dilated cardiomyopathy	0.000624	0.00323	CcSEcCtD
Diclofenac—Face oedema—Lisinopril—dilated cardiomyopathy	0.000621	0.00321	CcSEcCtD
Diclofenac—Agranulocytosis—Furosemide—dilated cardiomyopathy	0.000616	0.00319	CcSEcCtD
Diclofenac—Urticaria—Spironolactone—dilated cardiomyopathy	0.000615	0.00318	CcSEcCtD
Diclofenac—Irritability—Lisinopril—dilated cardiomyopathy	0.000614	0.00318	CcSEcCtD
Diclofenac—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.000612	0.00317	CcSEcCtD
Diclofenac—Blood creatinine increased—Lisinopril—dilated cardiomyopathy	0.000602	0.00312	CcSEcCtD
Diclofenac—CYP1A1—heart—dilated cardiomyopathy	0.0006	0.0128	CbGeAlD
Diclofenac—Urinary tract disorder—Furosemide—dilated cardiomyopathy	0.000585	0.00303	CcSEcCtD
Diclofenac—CYP2B6—heart—dilated cardiomyopathy	0.000583	0.0124	CbGeAlD
Diclofenac—Urethral disorder—Furosemide—dilated cardiomyopathy	0.000581	0.00301	CcSEcCtD
Diclofenac—Cramp muscle—Lisinopril—dilated cardiomyopathy	0.000579	0.003	CcSEcCtD
Diclofenac—Toxic epidermal necrolysis—Lisinopril—dilated cardiomyopathy	0.000579	0.003	CcSEcCtD
Diclofenac—CYP2C9—heart—dilated cardiomyopathy	0.000577	0.0123	CbGeAlD
Diclofenac—Nasopharyngitis—Lisinopril—dilated cardiomyopathy	0.000575	0.00298	CcSEcCtD
Diclofenac—Visual impairment—Furosemide—dilated cardiomyopathy	0.000571	0.00296	CcSEcCtD
Diclofenac—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.00057	0.00295	CcSEcCtD
Diclofenac—Gastritis—Lisinopril—dilated cardiomyopathy	0.000569	0.00295	CcSEcCtD
Diclofenac—Erythema multiforme—Furosemide—dilated cardiomyopathy	0.00056	0.0029	CcSEcCtD
Diclofenac—Asthma—Lisinopril—dilated cardiomyopathy	0.000556	0.00288	CcSEcCtD
Diclofenac—Influenza—Lisinopril—dilated cardiomyopathy	0.000556	0.00288	CcSEcCtD
Diclofenac—Eye disorder—Furosemide—dilated cardiomyopathy	0.000554	0.00287	CcSEcCtD
Diclofenac—Tinnitus—Furosemide—dilated cardiomyopathy	0.000553	0.00286	CcSEcCtD
Diclofenac—Eosinophilia—Lisinopril—dilated cardiomyopathy	0.00055	0.00285	CcSEcCtD
Diclofenac—Pruritus—Spironolactone—dilated cardiomyopathy	0.000548	0.00284	CcSEcCtD
Diclofenac—Bronchospasm—Lisinopril—dilated cardiomyopathy	0.000547	0.00283	CcSEcCtD
Diclofenac—Pancreatitis—Lisinopril—dilated cardiomyopathy	0.000545	0.00282	CcSEcCtD
Diclofenac—Angina pectoris—Lisinopril—dilated cardiomyopathy	0.000541	0.0028	CcSEcCtD
Diclofenac—Sweating increased—Lisinopril—dilated cardiomyopathy	0.000541	0.0028	CcSEcCtD
Diclofenac—Angiopathy—Furosemide—dilated cardiomyopathy	0.000538	0.00278	CcSEcCtD
Diclofenac—Immune system disorder—Furosemide—dilated cardiomyopathy	0.000535	0.00277	CcSEcCtD
Diclofenac—Bronchitis—Lisinopril—dilated cardiomyopathy	0.000534	0.00277	CcSEcCtD
Diclofenac—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.00053	0.00274	CcSEcCtD
Diclofenac—Arrhythmia—Furosemide—dilated cardiomyopathy	0.00053	0.00274	CcSEcCtD
Diclofenac—Pancytopenia—Lisinopril—dilated cardiomyopathy	0.000528	0.00273	CcSEcCtD
Diclofenac—PTGS1—heart—dilated cardiomyopathy	0.000527	0.0112	CbGeAlD
Diclofenac—Dysuria—Lisinopril—dilated cardiomyopathy	0.00052	0.00269	CcSEcCtD
Diclofenac—Upper respiratory tract infection—Lisinopril—dilated cardiomyopathy	0.000516	0.00267	CcSEcCtD
Diclofenac—Erythema—Furosemide—dilated cardiomyopathy	0.000516	0.00267	CcSEcCtD
Diclofenac—Malnutrition—Furosemide—dilated cardiomyopathy	0.000516	0.00267	CcSEcCtD
Diclofenac—CYP1A1—cardiac atrium—dilated cardiomyopathy	0.000513	0.0109	CbGeAlD
Diclofenac—Dizziness—Spironolactone—dilated cardiomyopathy	0.000512	0.00265	CcSEcCtD
Diclofenac—Erectile dysfunction—Lisinopril—dilated cardiomyopathy	0.000512	0.00265	CcSEcCtD
Diclofenac—Flatulence—Furosemide—dilated cardiomyopathy	0.000508	0.00263	CcSEcCtD
Diclofenac—Photosensitivity reaction—Lisinopril—dilated cardiomyopathy	0.000507	0.00263	CcSEcCtD
Diclofenac—Weight increased—Lisinopril—dilated cardiomyopathy	0.000506	0.00262	CcSEcCtD
Diclofenac—Dysgeusia—Furosemide—dilated cardiomyopathy	0.000505	0.00262	CcSEcCtD
Diclofenac—PTGS2—heart—dilated cardiomyopathy	0.000504	0.0107	CbGeAlD
Diclofenac—Weight decreased—Lisinopril—dilated cardiomyopathy	0.000503	0.0026	CcSEcCtD
Diclofenac—Hyperglycaemia—Lisinopril—dilated cardiomyopathy	0.000501	0.0026	CcSEcCtD
Diclofenac—Pneumonia—Lisinopril—dilated cardiomyopathy	0.000498	0.00258	CcSEcCtD
Diclofenac—Muscle spasms—Furosemide—dilated cardiomyopathy	0.000496	0.00257	CcSEcCtD
Diclofenac—Depression—Lisinopril—dilated cardiomyopathy	0.000494	0.00256	CcSEcCtD
Diclofenac—Vomiting—Spironolactone—dilated cardiomyopathy	0.000492	0.00255	CcSEcCtD
Diclofenac—Stevens-Johnson syndrome—Lisinopril—dilated cardiomyopathy	0.000491	0.00254	CcSEcCtD
Diclofenac—Acute coronary syndrome—Lisinopril—dilated cardiomyopathy	0.000488	0.00253	CcSEcCtD
Diclofenac—Rash—Spironolactone—dilated cardiomyopathy	0.000488	0.00253	CcSEcCtD
Diclofenac—Dermatitis—Spironolactone—dilated cardiomyopathy	0.000488	0.00252	CcSEcCtD
Diclofenac—Renal failure—Lisinopril—dilated cardiomyopathy	0.000487	0.00252	CcSEcCtD
Diclofenac—Vision blurred—Furosemide—dilated cardiomyopathy	0.000486	0.00252	CcSEcCtD
Diclofenac—Myocardial infarction—Lisinopril—dilated cardiomyopathy	0.000486	0.00251	CcSEcCtD
Diclofenac—Neuropathy peripheral—Lisinopril—dilated cardiomyopathy	0.000486	0.00251	CcSEcCtD
Diclofenac—Headache—Spironolactone—dilated cardiomyopathy	0.000485	0.00251	CcSEcCtD
Diclofenac—Jaundice—Lisinopril—dilated cardiomyopathy	0.000483	0.0025	CcSEcCtD
Diclofenac—Urinary tract infection—Lisinopril—dilated cardiomyopathy	0.000482	0.00249	CcSEcCtD
Diclofenac—Anaemia—Furosemide—dilated cardiomyopathy	0.000477	0.00247	CcSEcCtD
Diclofenac—Sweating—Lisinopril—dilated cardiomyopathy	0.000475	0.00246	CcSEcCtD
Diclofenac—Agitation—Furosemide—dilated cardiomyopathy	0.000474	0.00246	CcSEcCtD
Diclofenac—Haematuria—Lisinopril—dilated cardiomyopathy	0.000472	0.00245	CcSEcCtD
Diclofenac—Hepatobiliary disease—Lisinopril—dilated cardiomyopathy	0.000469	0.00243	CcSEcCtD
Diclofenac—Epistaxis—Lisinopril—dilated cardiomyopathy	0.000467	0.00242	CcSEcCtD
Diclofenac—Sinusitis—Lisinopril—dilated cardiomyopathy	0.000465	0.00241	CcSEcCtD
Diclofenac—Vertigo—Furosemide—dilated cardiomyopathy	0.000464	0.0024	CcSEcCtD
Diclofenac—Agranulocytosis—Lisinopril—dilated cardiomyopathy	0.000462	0.00239	CcSEcCtD
Diclofenac—Leukopenia—Furosemide—dilated cardiomyopathy	0.000462	0.00239	CcSEcCtD
Diclofenac—Nausea—Spironolactone—dilated cardiomyopathy	0.00046	0.00238	CcSEcCtD
Diclofenac—Bradycardia—Lisinopril—dilated cardiomyopathy	0.000453	0.00234	CcSEcCtD
Diclofenac—PTGS1—cardiac atrium—dilated cardiomyopathy	0.000451	0.0096	CbGeAlD
Diclofenac—Rhinitis—Lisinopril—dilated cardiomyopathy	0.000446	0.00231	CcSEcCtD
Diclofenac—Hepatitis—Lisinopril—dilated cardiomyopathy	0.000445	0.0023	CcSEcCtD
Diclofenac—Hallucination—Lisinopril—dilated cardiomyopathy	0.000443	0.00229	CcSEcCtD
Diclofenac—Pharyngitis—Lisinopril—dilated cardiomyopathy	0.000441	0.00229	CcSEcCtD
Diclofenac—Urinary tract disorder—Lisinopril—dilated cardiomyopathy	0.000439	0.00227	CcSEcCtD
Diclofenac—Oedema peripheral—Lisinopril—dilated cardiomyopathy	0.000438	0.00227	CcSEcCtD
Diclofenac—Unspecified disorder of skin and subcutaneous tissue—Furosemide—dilated cardiomyopathy	0.000436	0.00226	CcSEcCtD
Diclofenac—Urethral disorder—Lisinopril—dilated cardiomyopathy	0.000436	0.00226	CcSEcCtD
Diclofenac—Dry mouth—Furosemide—dilated cardiomyopathy	0.00043	0.00222	CcSEcCtD
Diclofenac—Confusional state—Furosemide—dilated cardiomyopathy	0.000425	0.0022	CcSEcCtD
Diclofenac—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.000421	0.00218	CcSEcCtD
Diclofenac—Erythema multiforme—Lisinopril—dilated cardiomyopathy	0.000421	0.00218	CcSEcCtD
Diclofenac—Tinnitus—Lisinopril—dilated cardiomyopathy	0.000415	0.00215	CcSEcCtD
Diclofenac—Shock—Furosemide—dilated cardiomyopathy	0.000414	0.00215	CcSEcCtD
Diclofenac—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.000413	0.00214	CcSEcCtD
Diclofenac—Flushing—Lisinopril—dilated cardiomyopathy	0.000413	0.00214	CcSEcCtD
Diclofenac—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.000412	0.00213	CcSEcCtD
Diclofenac—Skin disorder—Furosemide—dilated cardiomyopathy	0.000409	0.00212	CcSEcCtD
Diclofenac—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.000407	0.00211	CcSEcCtD
Diclofenac—Angiopathy—Lisinopril—dilated cardiomyopathy	0.000404	0.00209	CcSEcCtD
Diclofenac—Anorexia—Furosemide—dilated cardiomyopathy	0.000401	0.00208	CcSEcCtD
Diclofenac—Mediastinal disorder—Lisinopril—dilated cardiomyopathy	0.000401	0.00208	CcSEcCtD
Diclofenac—Chills—Lisinopril—dilated cardiomyopathy	0.000399	0.00207	CcSEcCtD
Diclofenac—Arrhythmia—Lisinopril—dilated cardiomyopathy	0.000397	0.00206	CcSEcCtD
Diclofenac—Hypotension—Furosemide—dilated cardiomyopathy	0.000394	0.00204	CcSEcCtD
Diclofenac—Alopecia—Lisinopril—dilated cardiomyopathy	0.000393	0.00203	CcSEcCtD
Diclofenac—Mental disorder—Lisinopril—dilated cardiomyopathy	0.00039	0.00202	CcSEcCtD
Diclofenac—Malnutrition—Lisinopril—dilated cardiomyopathy	0.000387	0.002	CcSEcCtD
Diclofenac—Erythema—Lisinopril—dilated cardiomyopathy	0.000387	0.002	CcSEcCtD
Diclofenac—Flatulence—Lisinopril—dilated cardiomyopathy	0.000382	0.00198	CcSEcCtD
Diclofenac—Tension—Lisinopril—dilated cardiomyopathy	0.00038	0.00197	CcSEcCtD
Diclofenac—Dysgeusia—Lisinopril—dilated cardiomyopathy	0.000379	0.00196	CcSEcCtD
Diclofenac—Paraesthesia—Furosemide—dilated cardiomyopathy	0.000378	0.00196	CcSEcCtD
Diclofenac—Nervousness—Lisinopril—dilated cardiomyopathy	0.000376	0.00195	CcSEcCtD
Diclofenac—Back pain—Lisinopril—dilated cardiomyopathy	0.000375	0.00194	CcSEcCtD
Diclofenac—Somnolence—Furosemide—dilated cardiomyopathy	0.000374	0.00194	CcSEcCtD
Diclofenac—Muscle spasms—Lisinopril—dilated cardiomyopathy	0.000372	0.00193	CcSEcCtD
Diclofenac—Decreased appetite—Furosemide—dilated cardiomyopathy	0.000366	0.0019	CcSEcCtD
Diclofenac—Vision blurred—Lisinopril—dilated cardiomyopathy	0.000365	0.00189	CcSEcCtD
Diclofenac—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.000364	0.00188	CcSEcCtD
Diclofenac—Fatigue—Furosemide—dilated cardiomyopathy	0.000363	0.00188	CcSEcCtD
Diclofenac—Tremor—Lisinopril—dilated cardiomyopathy	0.000363	0.00188	CcSEcCtD
Diclofenac—Pain—Furosemide—dilated cardiomyopathy	0.00036	0.00186	CcSEcCtD
Diclofenac—Constipation—Furosemide—dilated cardiomyopathy	0.00036	0.00186	CcSEcCtD
Diclofenac—Ill-defined disorder—Lisinopril—dilated cardiomyopathy	0.000359	0.00186	CcSEcCtD
Diclofenac—Anaemia—Lisinopril—dilated cardiomyopathy	0.000358	0.00185	CcSEcCtD
Diclofenac—Angioedema—Lisinopril—dilated cardiomyopathy	0.000354	0.00183	CcSEcCtD
Diclofenac—Malaise—Lisinopril—dilated cardiomyopathy	0.000349	0.00181	CcSEcCtD
Diclofenac—Vertigo—Lisinopril—dilated cardiomyopathy	0.000348	0.0018	CcSEcCtD
Diclofenac—Syncope—Lisinopril—dilated cardiomyopathy	0.000347	0.0018	CcSEcCtD
Diclofenac—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.000347	0.0018	CcSEcCtD
Diclofenac—Leukopenia—Lisinopril—dilated cardiomyopathy	0.000347	0.00179	CcSEcCtD
Diclofenac—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.000344	0.00178	CcSEcCtD
Diclofenac—Palpitations—Lisinopril—dilated cardiomyopathy	0.000342	0.00177	CcSEcCtD
Diclofenac—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.00034	0.00176	CcSEcCtD
Diclofenac—Cough—Lisinopril—dilated cardiomyopathy	0.000338	0.00175	CcSEcCtD
Diclofenac—Urticaria—Furosemide—dilated cardiomyopathy	0.000335	0.00173	CcSEcCtD
Diclofenac—Body temperature increased—Furosemide—dilated cardiomyopathy	0.000333	0.00172	CcSEcCtD
Diclofenac—Abdominal pain—Furosemide—dilated cardiomyopathy	0.000333	0.00172	CcSEcCtD
Diclofenac—Arthralgia—Lisinopril—dilated cardiomyopathy	0.00033	0.00171	CcSEcCtD
Diclofenac—Myalgia—Lisinopril—dilated cardiomyopathy	0.00033	0.00171	CcSEcCtD
Diclofenac—Chest pain—Lisinopril—dilated cardiomyopathy	0.00033	0.00171	CcSEcCtD
Diclofenac—Anxiety—Lisinopril—dilated cardiomyopathy	0.000328	0.0017	CcSEcCtD
Diclofenac—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—dilated cardiomyopathy	0.000327	0.00169	CcSEcCtD
Diclofenac—Discomfort—Lisinopril—dilated cardiomyopathy	0.000326	0.00169	CcSEcCtD
Diclofenac—Dry mouth—Lisinopril—dilated cardiomyopathy	0.000322	0.00167	CcSEcCtD
Diclofenac—Confusional state—Lisinopril—dilated cardiomyopathy	0.000319	0.00165	CcSEcCtD
Diclofenac—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.000316	0.00164	CcSEcCtD
Diclofenac—Oedema—Lisinopril—dilated cardiomyopathy	0.000316	0.00164	CcSEcCtD
Diclofenac—Infection—Lisinopril—dilated cardiomyopathy	0.000314	0.00163	CcSEcCtD
Diclofenac—ABCB1—heart—dilated cardiomyopathy	0.000312	0.00663	CbGeAlD
Diclofenac—Shock—Lisinopril—dilated cardiomyopathy	0.000311	0.00161	CcSEcCtD
Diclofenac—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.00031	0.00161	CcSEcCtD
Diclofenac—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.000309	0.0016	CcSEcCtD
Diclofenac—Tachycardia—Lisinopril—dilated cardiomyopathy	0.000308	0.0016	CcSEcCtD
Diclofenac—Skin disorder—Lisinopril—dilated cardiomyopathy	0.000307	0.00159	CcSEcCtD
Diclofenac—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.000305	0.00158	CcSEcCtD
Diclofenac—Asthenia—Furosemide—dilated cardiomyopathy	0.000302	0.00156	CcSEcCtD
Diclofenac—Anorexia—Lisinopril—dilated cardiomyopathy	0.000301	0.00156	CcSEcCtD
Diclofenac—Pruritus—Furosemide—dilated cardiomyopathy	0.000298	0.00154	CcSEcCtD
Diclofenac—Hypotension—Lisinopril—dilated cardiomyopathy	0.000295	0.00153	CcSEcCtD
Diclofenac—Diarrhoea—Furosemide—dilated cardiomyopathy	0.000288	0.00149	CcSEcCtD
Diclofenac—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.000288	0.00149	CcSEcCtD
Diclofenac—Insomnia—Lisinopril—dilated cardiomyopathy	0.000286	0.00148	CcSEcCtD
Diclofenac—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.000284	0.00147	CcSEcCtD
Diclofenac—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.000282	0.00146	CcSEcCtD
Diclofenac—Somnolence—Lisinopril—dilated cardiomyopathy	0.000281	0.00145	CcSEcCtD
Diclofenac—Dizziness—Furosemide—dilated cardiomyopathy	0.000278	0.00144	CcSEcCtD
Diclofenac—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.000278	0.00144	CcSEcCtD
Diclofenac—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.000275	0.00142	CcSEcCtD
Diclofenac—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.000273	0.00141	CcSEcCtD
Diclofenac—Fatigue—Lisinopril—dilated cardiomyopathy	0.000272	0.00141	CcSEcCtD
Diclofenac—Pain—Lisinopril—dilated cardiomyopathy	0.00027	0.0014	CcSEcCtD
Diclofenac—Constipation—Lisinopril—dilated cardiomyopathy	0.00027	0.0014	CcSEcCtD
Diclofenac—Vomiting—Furosemide—dilated cardiomyopathy	0.000268	0.00139	CcSEcCtD
Diclofenac—Rash—Furosemide—dilated cardiomyopathy	0.000266	0.00137	CcSEcCtD
Diclofenac—Dermatitis—Furosemide—dilated cardiomyopathy	0.000265	0.00137	CcSEcCtD
Diclofenac—Headache—Furosemide—dilated cardiomyopathy	0.000264	0.00137	CcSEcCtD
Diclofenac—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.00026	0.00135	CcSEcCtD
Diclofenac—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.000258	0.00134	CcSEcCtD
Diclofenac—Urticaria—Lisinopril—dilated cardiomyopathy	0.000251	0.0013	CcSEcCtD
Diclofenac—Nausea—Furosemide—dilated cardiomyopathy	0.00025	0.0013	CcSEcCtD
Diclofenac—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.00025	0.00129	CcSEcCtD
Diclofenac—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.00025	0.00129	CcSEcCtD
Diclofenac—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.000233	0.00121	CcSEcCtD
Diclofenac—Asthenia—Lisinopril—dilated cardiomyopathy	0.000227	0.00117	CcSEcCtD
Diclofenac—Pruritus—Lisinopril—dilated cardiomyopathy	0.000224	0.00116	CcSEcCtD
Diclofenac—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.000216	0.00112	CcSEcCtD
Diclofenac—Dizziness—Lisinopril—dilated cardiomyopathy	0.000209	0.00108	CcSEcCtD
Diclofenac—Vomiting—Lisinopril—dilated cardiomyopathy	0.000201	0.00104	CcSEcCtD
Diclofenac—Rash—Lisinopril—dilated cardiomyopathy	0.000199	0.00103	CcSEcCtD
Diclofenac—Dermatitis—Lisinopril—dilated cardiomyopathy	0.000199	0.00103	CcSEcCtD
Diclofenac—Headache—Lisinopril—dilated cardiomyopathy	0.000198	0.00102	CcSEcCtD
Diclofenac—Nausea—Lisinopril—dilated cardiomyopathy	0.000188	0.000972	CcSEcCtD
Diclofenac—ALOX5—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	6.81e-05	0.000412	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—SDHA—dilated cardiomyopathy	6.77e-05	0.00041	CbGpPWpGaD
Diclofenac—CXCL8—GPCR ligand binding—AGT—dilated cardiomyopathy	6.57e-05	0.000398	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	6.55e-05	0.000396	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—SDHA—dilated cardiomyopathy	6.53e-05	0.000395	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—ANKRD1—dilated cardiomyopathy	6.49e-05	0.000393	CbGpPWpGaD
Diclofenac—CXCL8—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	6.38e-05	0.000386	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—ACTN2—dilated cardiomyopathy	6.35e-05	0.000385	CbGpPWpGaD
Diclofenac—ALB—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	6.34e-05	0.000384	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—AGTR1—dilated cardiomyopathy	6.27e-05	0.00038	CbGpPWpGaD
Diclofenac—CXCL8—Signaling by GPCR—AGTR2—dilated cardiomyopathy	6.23e-05	0.000377	CbGpPWpGaD
Diclofenac—CXCL8—Signaling by GPCR—CXCL2—dilated cardiomyopathy	6.23e-05	0.000377	CbGpPWpGaD
Diclofenac—PTGS2—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	6.21e-05	0.000376	CbGpPWpGaD
Diclofenac—ABCC4—Platelet activation, signaling and aggregation—RAF1—dilated cardiomyopathy	6.19e-05	0.000375	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—PSEN2—dilated cardiomyopathy	6.18e-05	0.000374	CbGpPWpGaD
Diclofenac—CXCL8—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	6.18e-05	0.000374	CbGpPWpGaD
Diclofenac—ALB—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	6.17e-05	0.000374	CbGpPWpGaD
Diclofenac—ALB—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	6.17e-05	0.000374	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	6.15e-05	0.000373	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—TAZ—dilated cardiomyopathy	6.1e-05	0.00037	CbGpPWpGaD
Diclofenac—ABCC4—Hemostasis—ITGB1—dilated cardiomyopathy	5.99e-05	0.000363	CbGpPWpGaD
Diclofenac—PTGS2—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	5.99e-05	0.000363	CbGpPWpGaD
Diclofenac—PTGS1—Selenium Micronutrient Network—TNF—dilated cardiomyopathy	5.95e-05	0.000361	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—ADRB2—dilated cardiomyopathy	5.95e-05	0.00036	CbGpPWpGaD
Diclofenac—ALB—Vitamin B12 Metabolism—TNF—dilated cardiomyopathy	5.92e-05	0.000358	CbGpPWpGaD
Diclofenac—PTGS2—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	5.87e-05	0.000356	CbGpPWpGaD
Diclofenac—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—CD36—dilated cardiomyopathy	5.8e-05	0.000351	CbGpPWpGaD
Diclofenac—CXCL8—Signaling by GPCR—CXCR3—dilated cardiomyopathy	5.79e-05	0.000351	CbGpPWpGaD
Diclofenac—SCN4A—Developmental Biology—RAF1—dilated cardiomyopathy	5.76e-05	0.000349	CbGpPWpGaD
Diclofenac—SLCO1C1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	5.75e-05	0.000348	CbGpPWpGaD
Diclofenac—ALB—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	5.73e-05	0.000347	CbGpPWpGaD
Diclofenac—CXCL8—Signaling by GPCR—ADRB1—dilated cardiomyopathy	5.61e-05	0.00034	CbGpPWpGaD
Diclofenac—ABCB1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	5.56e-05	0.000336	CbGpPWpGaD
Diclofenac—SCN4A—Axon guidance—EGFR—dilated cardiomyopathy	5.54e-05	0.000335	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—SDHA—dilated cardiomyopathy	5.52e-05	0.000334	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—CXCL2—dilated cardiomyopathy	5.49e-05	0.000332	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—AGTR2—dilated cardiomyopathy	5.49e-05	0.000332	CbGpPWpGaD
Diclofenac—ABCB1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	5.4e-05	0.000327	CbGpPWpGaD
Diclofenac—ABCB1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	5.4e-05	0.000327	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—VCL—dilated cardiomyopathy	5.4e-05	0.000327	CbGpPWpGaD
Diclofenac—CXCL8—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	5.28e-05	0.00032	CbGpPWpGaD
Diclofenac—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—AGT—dilated cardiomyopathy	5.22e-05	0.000316	CbGpPWpGaD
Diclofenac—KCNQ2—Developmental Biology—EGFR—dilated cardiomyopathy	5.21e-05	0.000316	CbGpPWpGaD
Diclofenac—KCNQ3—Developmental Biology—EGFR—dilated cardiomyopathy	5.21e-05	0.000316	CbGpPWpGaD
Diclofenac—CXCR1—Signaling by GPCR—RAF1—dilated cardiomyopathy	5.18e-05	0.000314	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—ANKRD1—dilated cardiomyopathy	5.15e-05	0.000312	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	5.11e-05	0.00031	CbGpPWpGaD
Diclofenac—ABCC4—Hemostasis—CD36—dilated cardiomyopathy	5.11e-05	0.00031	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—CXCR3—dilated cardiomyopathy	5.1e-05	0.000309	CbGpPWpGaD
Diclofenac—ABCB1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	5.02e-05	0.000304	CbGpPWpGaD
Diclofenac—CXCL8—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	5.01e-05	0.000303	CbGpPWpGaD
Diclofenac—KCNQ2—Developmental Biology—TNF—dilated cardiomyopathy	4.96e-05	0.000301	CbGpPWpGaD
Diclofenac—KCNQ3—Developmental Biology—TNF—dilated cardiomyopathy	4.96e-05	0.000301	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—ANKRD1—dilated cardiomyopathy	4.95e-05	0.0003	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—ADRB1—dilated cardiomyopathy	4.94e-05	0.000299	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—ANKRD1—dilated cardiomyopathy	4.85e-05	0.000294	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—TAZ—dilated cardiomyopathy	4.84e-05	0.000293	CbGpPWpGaD
Diclofenac—ABCC4—Hemostasis—RAC1—dilated cardiomyopathy	4.82e-05	0.000292	CbGpPWpGaD
Diclofenac—ALB—Folate Metabolism—TNF—dilated cardiomyopathy	4.81e-05	0.000292	CbGpPWpGaD
Diclofenac—CXCL8—Signaling by GPCR—AGTR1—dilated cardiomyopathy	4.79e-05	0.00029	CbGpPWpGaD
Diclofenac—PTGS2—Selenium Micronutrient Network—TNF—dilated cardiomyopathy	4.73e-05	0.000286	CbGpPWpGaD
Diclofenac—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—dilated cardiomyopathy	4.72e-05	0.000286	CbGpPWpGaD
Diclofenac—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—dilated cardiomyopathy	4.72e-05	0.000286	CbGpPWpGaD
Diclofenac—PLA2G2A—Metabolism—GPX1—dilated cardiomyopathy	4.71e-05	0.000285	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—TAZ—dilated cardiomyopathy	4.66e-05	0.000282	CbGpPWpGaD
Diclofenac—CXCL8—Metabolism of proteins—AGT—dilated cardiomyopathy	4.62e-05	0.00028	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—RAC1—dilated cardiomyopathy	4.62e-05	0.00028	CbGpPWpGaD
Diclofenac—PLA2G2A—Metabolism—CD36—dilated cardiomyopathy	4.59e-05	0.000278	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—ANKRD1—dilated cardiomyopathy	4.57e-05	0.000277	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—TAZ—dilated cardiomyopathy	4.56e-05	0.000276	CbGpPWpGaD
Diclofenac—CXCL8—Signaling by GPCR—ADRB2—dilated cardiomyopathy	4.55e-05	0.000275	CbGpPWpGaD
Diclofenac—CYP1A2—Aryl Hydrocarbon Receptor—TNF—dilated cardiomyopathy	4.49e-05	0.000272	CbGpPWpGaD
Diclofenac—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—dilated cardiomyopathy	4.49e-05	0.000272	CbGpPWpGaD
Diclofenac—ALB—Platelet activation, signaling and aggregation—CD36—dilated cardiomyopathy	4.49e-05	0.000272	CbGpPWpGaD
Diclofenac—TTR—Disease—RAC1—dilated cardiomyopathy	4.44e-05	0.000269	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—AGT—dilated cardiomyopathy	4.41e-05	0.000267	CbGpPWpGaD
Diclofenac—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	4.4e-05	0.000267	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—SDHA—dilated cardiomyopathy	4.38e-05	0.000265	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—TAZ—dilated cardiomyopathy	4.3e-05	0.00026	CbGpPWpGaD
Diclofenac—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	4.25e-05	0.000257	CbGpPWpGaD
Diclofenac—ALB—Platelet activation, signaling and aggregation—RAC1—dilated cardiomyopathy	4.23e-05	0.000256	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—AGTR1—dilated cardiomyopathy	4.22e-05	0.000256	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—SDHA—dilated cardiomyopathy	4.21e-05	0.000255	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—ANKRD1—dilated cardiomyopathy	4.19e-05	0.000254	CbGpPWpGaD
Diclofenac—ALB—Metabolism—ANKRD1—dilated cardiomyopathy	4.17e-05	0.000252	CbGpPWpGaD
Diclofenac—ABCB1—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	4.16e-05	0.000252	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—PSEN2—dilated cardiomyopathy	4.15e-05	0.000251	CbGpPWpGaD
Diclofenac—PLA2G2A—Metabolism—AGT—dilated cardiomyopathy	4.13e-05	0.00025	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—SDHA—dilated cardiomyopathy	4.12e-05	0.00025	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—ADRB2—dilated cardiomyopathy	4e-05	0.000242	CbGpPWpGaD
Diclofenac—ABCC1—Disease—NPPA—dilated cardiomyopathy	3.99e-05	0.000242	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	3.98e-05	0.000241	CbGpPWpGaD
Diclofenac—SCN4A—Developmental Biology—EGFR—dilated cardiomyopathy	3.95e-05	0.000239	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—TAZ—dilated cardiomyopathy	3.94e-05	0.000239	CbGpPWpGaD
Diclofenac—PTGS2—Spinal Cord Injury—EGFR—dilated cardiomyopathy	3.93e-05	0.000238	CbGpPWpGaD
Diclofenac—ALB—Metabolism—TAZ—dilated cardiomyopathy	3.92e-05	0.000237	CbGpPWpGaD
Diclofenac—PTGS2—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	3.89e-05	0.000236	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—SDHA—dilated cardiomyopathy	3.89e-05	0.000235	CbGpPWpGaD
Diclofenac—CXCL8—GPCR downstream signaling—RAC1—dilated cardiomyopathy	3.89e-05	0.000235	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	3.88e-05	0.000235	CbGpPWpGaD
Diclofenac—ABCC1—Disease—PSEN2—dilated cardiomyopathy	3.86e-05	0.000234	CbGpPWpGaD
Diclofenac—ALB—Selenium Micronutrient Network—TNF—dilated cardiomyopathy	3.82e-05	0.000232	CbGpPWpGaD
Diclofenac—SLC22A11—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	3.78e-05	0.000229	CbGpPWpGaD
Diclofenac—SCN4A—Developmental Biology—TNF—dilated cardiomyopathy	3.76e-05	0.000228	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—ANKRD1—dilated cardiomyopathy	3.74e-05	0.000227	CbGpPWpGaD
Diclofenac—PTGS2—Spinal Cord Injury—TNF—dilated cardiomyopathy	3.74e-05	0.000226	CbGpPWpGaD
Diclofenac—CXCL8—GPCR downstream signaling—AGT—dilated cardiomyopathy	3.71e-05	0.000225	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—CXCL2—dilated cardiomyopathy	3.68e-05	0.000223	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—AGTR2—dilated cardiomyopathy	3.68e-05	0.000223	CbGpPWpGaD
Diclofenac—ABCB1—Allograft Rejection—TNF—dilated cardiomyopathy	3.65e-05	0.000221	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—ANKRD1—dilated cardiomyopathy	3.65e-05	0.000221	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—SDHA—dilated cardiomyopathy	3.56e-05	0.000216	CbGpPWpGaD
Diclofenac—CXCR1—Signaling by GPCR—EGFR—dilated cardiomyopathy	3.56e-05	0.000215	CbGpPWpGaD
Diclofenac—ALB—Metabolism—SDHA—dilated cardiomyopathy	3.54e-05	0.000215	CbGpPWpGaD
Diclofenac—CXCL8—Signaling by GPCR—RAC1—dilated cardiomyopathy	3.53e-05	0.000214	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—TAZ—dilated cardiomyopathy	3.52e-05	0.000213	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	3.49e-05	0.000211	CbGpPWpGaD
Diclofenac—ALOX5—Metabolism—GPX1—dilated cardiomyopathy	3.46e-05	0.000209	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	3.44e-05	0.000208	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—TAZ—dilated cardiomyopathy	3.43e-05	0.000208	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—CXCR3—dilated cardiomyopathy	3.42e-05	0.000207	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—ANKRD1—dilated cardiomyopathy	3.41e-05	0.000207	CbGpPWpGaD
Diclofenac—CXCL8—Signaling by GPCR—AGT—dilated cardiomyopathy	3.37e-05	0.000204	CbGpPWpGaD
Diclofenac—ALOX5—Metabolism—CD36—dilated cardiomyopathy	3.37e-05	0.000204	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	3.37e-05	0.000204	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—ADRB1—dilated cardiomyopathy	3.31e-05	0.000201	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	3.28e-05	0.000199	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—TAZ—dilated cardiomyopathy	3.21e-05	0.000194	CbGpPWpGaD
Diclofenac—ABCC4—Hemostasis—RAF1—dilated cardiomyopathy	3.19e-05	0.000193	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—SDHA—dilated cardiomyopathy	3.18e-05	0.000193	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—RAC1—dilated cardiomyopathy	3.11e-05	0.000188	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—SDHA—dilated cardiomyopathy	3.11e-05	0.000188	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—RAF1—dilated cardiomyopathy	3.06e-05	0.000185	CbGpPWpGaD
Diclofenac—ALOX5—Metabolism—AGT—dilated cardiomyopathy	3.03e-05	0.000184	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—AGT—dilated cardiomyopathy	2.97e-05	0.00018	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	2.95e-05	0.000179	CbGpPWpGaD
Diclofenac—TTR—Disease—RAF1—dilated cardiomyopathy	2.94e-05	0.000178	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—ANKRD1—dilated cardiomyopathy	2.92e-05	0.000177	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—SDHA—dilated cardiomyopathy	2.9e-05	0.000176	CbGpPWpGaD
Diclofenac—SLC22A8—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	2.88e-05	0.000175	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—AGTR1—dilated cardiomyopathy	2.83e-05	0.000171	CbGpPWpGaD
Diclofenac—ALB—Platelet activation, signaling and aggregation—RAF1—dilated cardiomyopathy	2.8e-05	0.00017	CbGpPWpGaD
Diclofenac—ABCC4—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	2.76e-05	0.000167	CbGpPWpGaD
Diclofenac—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	2.76e-05	0.000167	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—TAZ—dilated cardiomyopathy	2.74e-05	0.000166	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—ITGB1—dilated cardiomyopathy	2.71e-05	0.000164	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—ADRB2—dilated cardiomyopathy	2.69e-05	0.000163	CbGpPWpGaD
Diclofenac—PTGS2—Disease—NPPA—dilated cardiomyopathy	2.68e-05	0.000162	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	2.67e-05	0.000162	CbGpPWpGaD
Diclofenac—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	2.67e-05	0.000162	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	2.6e-05	0.000158	CbGpPWpGaD
Diclofenac—PTGS2—Disease—PSEN2—dilated cardiomyopathy	2.59e-05	0.000157	CbGpPWpGaD
Diclofenac—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	2.54e-05	0.000154	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—SDHA—dilated cardiomyopathy	2.48e-05	0.00015	CbGpPWpGaD
Diclofenac—SLC22A6—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	2.41e-05	0.000146	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	2.37e-05	0.000144	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	2.34e-05	0.000142	CbGpPWpGaD
Diclofenac—CXCL8—Signaling by GPCR—RAF1—dilated cardiomyopathy	2.34e-05	0.000142	CbGpPWpGaD
Diclofenac—CYP2C18—Metabolism—GPX1—dilated cardiomyopathy	2.33e-05	0.000141	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—CD36—dilated cardiomyopathy	2.31e-05	0.00014	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	2.31e-05	0.00014	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	2.31e-05	0.00014	CbGpPWpGaD
Diclofenac—ABCC1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	2.3e-05	0.00014	CbGpPWpGaD
Diclofenac—CYP2C18—Metabolism—CD36—dilated cardiomyopathy	2.27e-05	0.000137	CbGpPWpGaD
Diclofenac—UGT2B7—Metabolism—GPX1—dilated cardiomyopathy	2.26e-05	0.000137	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—ANKRD1—dilated cardiomyopathy	2.25e-05	0.000136	CbGpPWpGaD
Diclofenac—UGT2B7—Metabolism—CD36—dilated cardiomyopathy	2.2e-05	0.000133	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—RAC1—dilated cardiomyopathy	2.18e-05	0.000132	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	2.17e-05	0.000132	CbGpPWpGaD
Diclofenac—ALB—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	2.16e-05	0.000131	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	2.12e-05	0.000128	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—TAZ—dilated cardiomyopathy	2.12e-05	0.000128	CbGpPWpGaD
Diclofenac—ALB—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	2.11e-05	0.000128	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—EGFR—dilated cardiomyopathy	2.1e-05	0.000127	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—RAC1—dilated cardiomyopathy	2.08e-05	0.000126	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	2.08e-05	0.000126	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—RAF1—dilated cardiomyopathy	2.06e-05	0.000125	CbGpPWpGaD
Diclofenac—CYP2C18—Metabolism—AGT—dilated cardiomyopathy	2.04e-05	0.000124	CbGpPWpGaD
Diclofenac—TTR—Disease—EGFR—dilated cardiomyopathy	2.02e-05	0.000122	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—AGT—dilated cardiomyopathy	1.99e-05	0.000121	CbGpPWpGaD
Diclofenac—UGT2B7—Metabolism—AGT—dilated cardiomyopathy	1.98e-05	0.00012	CbGpPWpGaD
Diclofenac—ABCC1—Disease—RAC1—dilated cardiomyopathy	1.94e-05	0.000118	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	1.94e-05	0.000118	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—SDHA—dilated cardiomyopathy	1.91e-05	0.000116	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	1.91e-05	0.000115	CbGpPWpGaD
Diclofenac—ALB—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	1.9e-05	0.000115	CbGpPWpGaD
Diclofenac—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	1.89e-05	0.000115	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	1.89e-05	0.000114	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—GPX1—dilated cardiomyopathy	1.84e-05	0.000111	CbGpPWpGaD
Diclofenac—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	1.8e-05	0.000109	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—CD36—dilated cardiomyopathy	1.79e-05	0.000108	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—GPX1—dilated cardiomyopathy	1.77e-05	0.000107	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	1.77e-05	0.000107	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—CD36—dilated cardiomyopathy	1.73e-05	0.000105	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	1.72e-05	0.000104	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	1.7e-05	0.000103	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—AGT—dilated cardiomyopathy	1.61e-05	9.77e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.6e-05	9.72e-05	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—AGT—dilated cardiomyopathy	1.55e-05	9.42e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	1.55e-05	9.4e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	1.51e-05	9.16e-05	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—GPX1—dilated cardiomyopathy	1.5e-05	9.08e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	1.47e-05	8.92e-05	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—CD36—dilated cardiomyopathy	1.46e-05	8.84e-05	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—RAF1—dilated cardiomyopathy	1.44e-05	8.75e-05	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—EGFR—dilated cardiomyopathy	1.41e-05	8.56e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—RAF1—dilated cardiomyopathy	1.38e-05	8.37e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	1.33e-05	8.03e-05	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—AGT—dilated cardiomyopathy	1.31e-05	7.96e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—RAC1—dilated cardiomyopathy	1.3e-05	7.9e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—RAF1—dilated cardiomyopathy	1.29e-05	7.8e-05	CbGpPWpGaD
Diclofenac—ALB—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.25e-05	7.58e-05	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—GPX1—dilated cardiomyopathy	1.19e-05	7.21e-05	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—CD36—dilated cardiomyopathy	1.16e-05	7.02e-05	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—GPX1—dilated cardiomyopathy	1.14e-05	6.93e-05	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—GPX1—dilated cardiomyopathy	1.12e-05	6.78e-05	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—CD36—dilated cardiomyopathy	1.11e-05	6.75e-05	CbGpPWpGaD
Diclofenac—ABCB1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.1e-05	6.64e-05	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—CD36—dilated cardiomyopathy	1.09e-05	6.61e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—GPX1—dilated cardiomyopathy	1.06e-05	6.4e-05	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—AGT—dilated cardiomyopathy	1.04e-05	6.32e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—CD36—dilated cardiomyopathy	1.03e-05	6.23e-05	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—AGT—dilated cardiomyopathy	1e-05	6.07e-05	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—AGT—dilated cardiomyopathy	9.82e-06	5.95e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—GPX1—dilated cardiomyopathy	9.68e-06	5.86e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—GPX1—dilated cardiomyopathy	9.63e-06	5.83e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—EGFR—dilated cardiomyopathy	9.48e-06	5.74e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—CD36—dilated cardiomyopathy	9.43e-06	5.71e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—CD36—dilated cardiomyopathy	9.38e-06	5.68e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—AGT—dilated cardiomyopathy	9.26e-06	5.61e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—EGFR—dilated cardiomyopathy	8.83e-06	5.35e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—RAF1—dilated cardiomyopathy	8.65e-06	5.24e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—GPX1—dilated cardiomyopathy	8.64e-06	5.23e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—AGT—dilated cardiomyopathy	8.49e-06	5.14e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—AGT—dilated cardiomyopathy	8.44e-06	5.11e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—GPX1—dilated cardiomyopathy	8.43e-06	5.11e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—CD36—dilated cardiomyopathy	8.42e-06	5.1e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—CD36—dilated cardiomyopathy	8.21e-06	4.98e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—GPX1—dilated cardiomyopathy	7.88e-06	4.77e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—CD36—dilated cardiomyopathy	7.67e-06	4.65e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—AGT—dilated cardiomyopathy	7.58e-06	4.59e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—AGT—dilated cardiomyopathy	7.4e-06	4.48e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—AGT—dilated cardiomyopathy	6.91e-06	4.18e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—GPX1—dilated cardiomyopathy	6.73e-06	4.08e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—CD36—dilated cardiomyopathy	6.56e-06	3.97e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—EGFR—dilated cardiomyopathy	5.93e-06	3.59e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—AGT—dilated cardiomyopathy	5.9e-06	3.58e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—GPX1—dilated cardiomyopathy	5.2e-06	3.15e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—CD36—dilated cardiomyopathy	5.06e-06	3.07e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—AGT—dilated cardiomyopathy	4.56e-06	2.76e-05	CbGpPWpGaD
